Jiang Peng, Wei Jing
Department of Paediatrics, Liaocheng People's Hospital, Liaocheng, China.
Department of Ultrasonography, Liaocheng People's Hospital, Liaocheng, China.
Front Pediatr. 2022 Jun 29;10:882056. doi: 10.3389/fped.2022.882056. eCollection 2022.
This study explored the application value of lung ultrasound (LUS) in neonatal ventilator-associated pneumonia (NVAP). In this study, 122 newborns suspected of NVAP were treated in the NICU of Liaocheng People's Hospital between July 1, 2020, and July 1, 2021. Of these, 115 were clinically diagnosed with NVAP. The diagnostic value of LUS for NVAP was determined by comparing the different signs of LUS and chest X-ray (CXR). The confirmed cases were divided into the failure and success groups according to the first ventilator weaning test results. The consistency between the results of LUS and CXR and the actual test results was compared between the two groups. Before treatment, the LUS findings of the confirmed cases showed a lung consolidation with air bronchogram sign (111/115), alveolar-interstitial syndrome (113/115), pleural effusion (12/115), pleural line abnormalities (114/115), and lung pulse (15/115). CXR showed 109 cases of pneumonia. Taking the clinical diagnosis of VAP as the gold standard, the lung consolidation with air bronchogram sign on LUS had a higher sensitivity, specificity, and accuracy for the diagnosis of NVAP than those of other LUS and CXR findings and showed better consistency with the clinical diagnosis ( = 0.983, kappa value = 0.761, < 0.05). After treatment, the 115 cases were divided into two groups according to the results of the first weaning from ventilation: the failed group (19 cases) and the successful group (96 cases). The lung consolidation with air bronchogram sign was used as the positive diagnostic standard of ultrasound. The sensitivity and specificity of LUS (94.7 and 89.6%, respectively) in evaluating the outcome of weaning from the ventilator of pneumonia were higher than those of CXR (73.7 and 84.4%, respectively). Additionally, the consistency of the LUS findings with the weaning results was higher than that of CXR ( = 0.922, kappa value = 0.709, < 0.05). Therefore, compared with CXR, LUS has a higher value in diagnosing NVAP and can better predict the results of the ventilator off-line test. LUS can replace CXR as the first imaging examination for NVAP.
本研究探讨了肺部超声(LUS)在新生儿呼吸机相关性肺炎(NVAP)中的应用价值。本研究中,2020年7月1日至2021年7月1日期间,122例疑似NVAP的新生儿在聊城市人民医院新生儿重症监护室接受治疗。其中,115例临床诊断为NVAP。通过比较LUS和胸部X线(CXR)的不同表现来确定LUS对NVAP的诊断价值。根据首次撤机试验结果将确诊病例分为失败组和成功组。比较两组LUS和CXR结果与实际试验结果之间的一致性。治疗前,确诊病例的LUS表现为肺实变伴空气支气管征(111/115)、肺泡-间质综合征(113/115)、胸腔积液(12/115)、胸膜线异常(114/115)和肺搏动(15/115)。CXR显示109例肺炎。以VAP的临床诊断为金标准,LUS上的肺实变伴空气支气管征对NVAP的诊断具有比其他LUS和CXR表现更高的敏感性、特异性和准确性,且与临床诊断显示出更好的一致性(=0.983,kappa值=0.761,<0.05)。治疗后,115例根据首次撤机结果分为两组:失败组(19例)和成功组(96例)。将肺实变伴空气支气管征作为超声阳性诊断标准。LUS评估肺炎撤机结果的敏感性和特异性(分别为94.7%和89.6%)高于CXR(分别为73.7%和84.4%)。此外,LUS表现与撤机结果的一致性高于CXR(=0.922,kappa值=0.709,<0.05)。因此,与CXR相比,LUS在诊断NVAP方面具有更高的价值,并且能够更好地预测撤机试验结果。LUS可替代CXR作为NVAP的首选影像学检查。